Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVERAGE France
NCT04356495Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jul 2020
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, ciclesonide, interferon beta-1b in coronavirus disease 2019 (COVID-19), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Jul 2020; status: completed.
02
Drugs
telmisartanciclesonideinterferon beta-1b
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04356495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356495.